Clinical trial
Japanese Dose-Response Study of Rimonabant in Obese Patients
NCT00459004 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00459004 |
|---|---|
| Title | Japanese Dose-Response Study of Rimonabant in Obese Patients |
| Official title | A Dose-Response Relationship Study of SR141716 in Obese Patients |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | rimonabant (SR141716) |
| Enrollment | 527 |
| Start date | Oct 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Apr 11, 2007 |
| Last update posted | Apr 7, 2009 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: